MF
Insider
Mark G Foletta
DirectorMark G Foletta (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in DexCom, Inc. (DXCM). The largest single filing was $331K of DXCM (4,000 sh across 2 lots, as filed), executed Jul 31.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$612K
shares × price, as filed
Last traded
Aug 3
Filed Aug 4
Median ADV $483.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
DXCMRecent filings
DXCMSALE
DexCom, Inc.
View filing →
$331K4,000 sh across 2 lots
Exec Jul 31
Filed Aug 4 · 4:38 PM ET DXCMSALE DexCom, Inc. View filing → $282K
3,801 sh × $74.10
Exec Jun 15
Filed Jun 17 · 5:30 PM ET DXCMSALE DexCom, Inc. View filing → $207K
2,555 sh × $81.02
Exec Aug 15 2025
Filed Aug 18 2025 · 5:30 PM ET DXCMSALE DexCom, Inc. View filing → $234K
2,742 sh × $85.17
Exec Jul 15 2025
Filed Jul 17 2025 · 5:30 PM ET DXCMSALE DexCom, Inc. View filing → $229K
2,750 sh × $83.13
Exec Jun 16 2025
Filed Jun 18 2025 · 5:30 PM ET